Dangerous blood clots increased with newer antipsychotic drugs

September 23, 2010, University of Nottingham

Taking newer types of antipsychotic drugs could increase a person’s risk of developing dangerous blood clots, according to a new University of Nottingham study published on bmj.com today.

Venous thromboembolism — a collective term for deep vein and — is an important and preventable cause of illness and death. Up to a quarter of affected patients die within a week and almost a third of survivors experience long-term effects.

There is already limited evidence that antipsychotic drugs, some of which are also prescribed for nausea, vomiting and vertigo, may be associated with an increased risk of .

Previous studies, however, have been small and restricted to certain population groups, or have not included newer ‘atypical’ antipsychotic drugs.

Researchers from The University of Nottingham and the Nottinghamshire County Teaching Primary Care Trust examined how these drugs affected people taking them, looking at the type of drug used, and the potency and dose involved.

Data for this study came from the UK QResearch primary care database, which holds the anonymised primary care clinical records of more than 11 million people registered at any time in the past 16 years with 525 UK general practices.

The Nottingham researchers, led by Professor Julia Hippisley-Cox at The University of Nottingham, looked at 25,532 eligible cases — 15,975 with and 9,557 pulmonary embolism — recorded between 1996 and 2007 in people aged between 16 and 100.

The cases were compared with 89,491 controls and showed that people prescribed antipsychotics in the previous 24 months had a 32 per cent greater risk of venous thromboembolism than non-users, even after adjusting for potential risk factors.

Risks were higher for new users, the researchers found, as patients who had started a new drug in the previous three months, had about twice the risk.

The risk was even greater for individuals prescribed atypical rather than conventional drugs. It also tended to be greater for patients prescribed low rather than high potency drugs.

However, the authors point out that the absolute risks were low, with an excess of four extra cases of venous thromboembolism per 10,000 patients treated over one year in patients of all ages, and 10 for patients aged 65 and over.

They conclude: “Though these findings add to the accumulating evidence of adverse health events associated with antipsychotic drugs, they should be confirmed with other data sources.

“If other studies replicate these findings, antipsychotic drugs should be used more cautiously for nausea and agitation etc, especially among patients at high risk of thromboembolism. Patients need information on the balance of risks and benefits of these drugs before they start treatment.”

In an accompanying editorial, geriatrics experts Rosa Liperoti and Giovanni Gambassi argue that a higher risk means treatment should be tailored according to individual risk factors.

“In clinical practice we need to be able to identify the best candidates for antipsychotic treatment … and those who may be more susceptible to developing side effects as a result of individual vascular risk factors possibly interacting with antipsychotics,” they say.

More information: URL for the paper: www.bmj.com/cgi/doi/10.1136/bmj.c4245

Related Stories

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.